| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/29/2009 | CN101417084A Traditional Chinese medicine for treating sciatica and preparation method thereof |
| 04/29/2009 | CN101417081A Quality control method of Longfengbao capsule |
| 04/29/2009 | CN101417048A Traditional Chinese medicine for treating senile psychosis |
| 04/29/2009 | CN101417034A Medicine composition for preventing the birth defect and improving the memory |
| 04/29/2009 | CN101417033A Traditional Chinese medicine for treating insomnia |
| 04/29/2009 | CN101417022A Traditional Chinese medicine for treating series headache |
| 04/29/2009 | CN101417021A External traditional Chinese medicine for giving up drug habits and preparation method and use thereof |
| 04/29/2009 | CN101417019A External medicine composition with anti-inflammation, detumescence and pain-easing function |
| 04/29/2009 | CN101417015A Medicine composition for preventing the birth defect and improving the memory |
| 04/29/2009 | CN101417012A Medicine composition for preventing the birth defect and improving the memory |
| 04/29/2009 | CN101417011A Medicine composition for preventing the birth defect and improving the memory |
| 04/29/2009 | CN101417010A Medicine composition for preventing the birth defect and improving the memory |
| 04/29/2009 | CN101416994A Medicine composition for prenatal and postnatal care and preventing the birth defect and improving the memory |
| 04/29/2009 | CN101416976A External medicine composition preparation with anti-inflammation detumescence pain-easing function |
| 04/29/2009 | CN101416967A Smoking abstention method |
| 04/29/2009 | CN101416948A Quetiapine fmarate dispersible tablets and preparation method thereof |
| 04/29/2009 | CN100482685C Tolerogenic peptides from myelin basic protein |
| 04/29/2009 | CN100482684C Cytokine protein family |
| 04/29/2009 | CN100482680C Prodrugs of excitatory amino acids |
| 04/29/2009 | CN100482664C 1,5-disubstituted-3,4-dihydro-1H-pyrimido [4,5-D] pyrimidi-2-one compounds and their use in treating CSBP/P38 kinase mediated diseases |
| 04/29/2009 | CN100482662C Heterocyclyl-3-sulfonylazaindole or-azaindazole derivatives as 5-hydroxytryptamine-6 ligands |
| 04/29/2009 | CN100482646C Derivative of n-[phenyl(piperidin-2-yl)methyl]benzamide, the preparation method thereof and application of same in therapeutics |
| 04/29/2009 | CN100482638C N-acylaminobenzene dervatives as selective monoamine oxidase b inhibitors |
| 04/29/2009 | CN100482280C Highly compressible ethylcellulose for tableting |
| 04/29/2009 | CN100482276C Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 04/29/2009 | CN100482265C Medicine for treating facial neuritis and its preparing method |
| 04/29/2009 | CN100482254C Method for extracting effective site of Xanthoceras sorbifolia hulled seed |
| 04/29/2009 | CN100482242C Compound recipe medicine for curing insomnia and its preparation method |
| 04/29/2009 | CN100482234C Stibene-glucoside oral liquid and its production method |
| 04/29/2009 | CN100482233C Compositions and methods for treating amyloidosis |
| 04/29/2009 | CN100482229C Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 04/29/2009 | CN100482226C Composition for covering flavor and preparation of containing the composition |
| 04/29/2009 | CN100482223C 5-halo-tryptamine derivatives used as ligands of 5-HT 6 and/or 5-HT7 serotonin receptors |
| 04/29/2009 | CN100482221C Use of nefopam for the treatment of nausea or emesis |
| 04/29/2009 | CN100482216C Use of hydroxide-releasing agents as skin permeation enhancers |
| 04/29/2009 | CN100482129C Health care medicated pillow |
| 04/28/2009 | US7524949 Prevention or therapy of cardiovascular complications |
| 04/28/2009 | US7524874 Vanilloid receptor ligands and their use in treatments |
| 04/28/2009 | US7524858 Substituted pyrroline kinase inhibitors |
| 04/28/2009 | US7524852 Bicyclic pyrimidine derivatives |
| 04/28/2009 | US7524847 Inhibit Dipeptidyl peptidase-IV; 7-(2-Butynyl)-3-methyl-3,7-dihydropurine-2,6-dione; suppress degradation of Glucagon-Like Peptide-1; enhance action of incretin; facilitate insulin secretion from pancreatic beta -cells due to glucose stimulus; postchallenge hyperglycemia, improved oral glucose tolerance |
| 04/28/2009 | US7524839 Such as 1-phenylsulfonyl-4-piperazinylindole hydrochloride for treatment or prophylaxis of disease mediated by serotonin related receptor, obesity, and/or central nervous system disorder |
| 04/28/2009 | US7524836 steroids such as (11 beta )-11-17-dihydroxy-21-[N-acetyl-S-(4-nitroxybutyroyl) cisteinyloxy]pregne-1,4-diene-3,20-dione having antiinflammatory, immunodepressive and angiostatic activity |
| 04/28/2009 | US7524812 A Omega-conopeptide, and the anitoxidant methionine, and either clonidine or baclofen; ziconotide retains its potency and is physically and chemically compatible with the analgesic; for intrathecal administration |
| 04/28/2009 | US7524643 Nucleotide sequences coding voltage gated calcium channels (VGCC) for treating neurological and cardiovascular disorders; anticonvulsant |
| 04/28/2009 | US7524484 Delivery of diphenhydramine through an inhalation route |
| 04/28/2009 | CA2555258C 1-isopropyl-2-oxo-1,2-dihydropyridine-3-carboxamide derivatives having 5-ht4 receptor agonistic activity |
| 04/28/2009 | CA2472954C Aza-arylpiperazines |
| 04/28/2009 | CA2336783C Novel 2,3,3a,4,9,9a hexahydro-8-hydroxy-1h-benz[f]indoles, a method for the production thereof, and their use as medicaments |
| 04/28/2009 | CA2273328C 5-cyclo indole compounds as 5-ht1d receptor ligands |
| 04/26/2009 | CA2641830A1 Use of therapeutic human albumin for the preparation of a drug for the treatment of patients suffering from cognitive disorders |
| 04/23/2009 | WO2009052454A2 Compositions and methods for ameliorating cns inflammation, psychosis, delirium, ptsd or ptss |
| 04/23/2009 | WO2009052350A1 Amine linked modulators of y-secretase |
| 04/23/2009 | WO2009052342A1 Combination therapy for reducing side effects using cannabinoid receptor ligands |
| 04/23/2009 | WO2009052334A1 Carbon linked modulators of y-secretase |
| 04/23/2009 | WO2009052310A1 A3 adenosine receptor antagonists |
| 04/23/2009 | WO2009052191A1 Internally masked neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use |
| 04/23/2009 | WO2009052126A1 PIPERIDINYL AND PIPERAZINYL MODULATORS OF γ-SECRETASE |
| 04/23/2009 | WO2009052079A1 Amide linked modulators of y-secretase |
| 04/23/2009 | WO2009052075A2 Method of treating motor disorders with alpha-2b adrenergic receptor agonists |
| 04/23/2009 | WO2009052073A2 Method of treating sensorimotor disorders with alpha-2 adrenergic receptor agonists |
| 04/23/2009 | WO2009052072A1 Treating motor disorders with 4-(1-(2,3-dimethylphenyl)ethyl)-1h-imidazole-2(3h)-thione |
| 04/23/2009 | WO2009052071A1 Treatment of sensorimotor disorders with 4- ( 1- ( 2, 3 -dimethylphenyl) ethyl) -1h-imidaz0le-2 ( 3h) -thione |
| 04/23/2009 | WO2009052068A1 Substituted n-phenyl-bipyrrolidine ureas and therapeutic use thereof |
| 04/23/2009 | WO2009052063A1 Substituted n-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof as histamine h3 receptor modulators |
| 04/23/2009 | WO2009052062A1 Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof |
| 04/23/2009 | WO2009051948A1 Biphenyl carboxylic acids and derivatives thereof |
| 04/23/2009 | WO2009051715A1 Quinolizidinone m1 receptor positive allosteric modulators |
| 04/23/2009 | WO2009051666A1 Therapeutic applications of fatty acid amide hydrolase inhibitors |
| 04/23/2009 | WO2009051660A2 Compounds for activating tgf-beta signaling |
| 04/23/2009 | WO2009051556A1 Tetrazole derivatives as modulators of metabotropic glutamate receptors (mglurs) |
| 04/23/2009 | WO2009051517A1 Pharmaceutical composition in the form of microcapsulated multicomponent particles made of n-carbfmoyl-methyl-4-phenyl-2-pyrrolidone and an auxiliary neutral organic low-molecular component and method for microcapsulation thereof |
| 04/23/2009 | WO2009051244A1 Heterocyclic compound |
| 04/23/2009 | WO2009051220A1 Antibody capable of specifically binding to aβ oligomer, and use thereof |
| 04/23/2009 | WO2009051217A1 Fentanyl-containing percutaneous absorption preparation |
| 04/23/2009 | WO2009051210A1 Method for producing pyrazole fused ring derivative |
| 04/23/2009 | WO2009051151A1 Therapeutic agent for trpv1-mediated disease |
| 04/23/2009 | WO2009050554A2 Pyrazolo [4, 3d] pyrimidine derivatives for use in promoting functional recovery |
| 04/23/2009 | WO2009050352A2 Imidazolone derivatives, preparation method thereof and biological use of same |
| 04/23/2009 | WO2009050348A1 Tricyclic n-heteroaryl-carboxamide derivatives, preparation thereof and therapeutic use of same |
| 04/23/2009 | WO2009050242A2 Heterocycle-substituted piperazino-dihydrothienopyrimidines |
| 04/23/2009 | WO2009050201A2 4-phenyl-5-oxo-imidazole derivatives, pharmaceutical compositions and uses therof |
| 04/23/2009 | WO2009050200A1 Imidazolidine-2,4-dione (hydantoin) derivatives useful as npy y2 receptor modulators |
| 04/23/2009 | WO2009050186A1 Trisubstituted 1,2,4-triazoles |
| 04/23/2009 | WO2009050185A1 1,3,5-trisubstituted triazole derivative |
| 04/23/2009 | WO2009049900A1 Novel nutraceutical compositions containing thymol and/or p-cymene or plant extracts for cognition |
| 04/23/2009 | WO2009049742A2 Use of melanotrophin-potentiating factor as a therapeutic agent |
| 04/23/2009 | WO2009049479A1 Polymorphs of donepezil salts, preparation methods and uses thereof |
| 04/23/2009 | WO2009049422A1 Compositions and methods for enhancing enzyme activity in gaucher, gm1 -gangliosidosis/morquio b disease. and parkinson's disease |
| 04/23/2009 | WO2009049421A1 Compositions and methods for enhancing enzyme activity in gaucher, gm1-gangliosidosis/morquio b disease, and parkinson's disease |
| 04/23/2009 | WO2009049354A1 Controlled-release pharmaceutical formulation |
| 04/23/2009 | WO2009032246A3 Particulate compositions for delivery of poorly soluble drugs |
| 04/23/2009 | WO2009030498A3 Use of gip for the treatment of disorders associated with dysfunctional synaptic transmission |
| 04/23/2009 | WO2009027820A3 Substituted-quinoxaline-type-piperidine compounds and the uses thereof |
| 04/23/2009 | WO2009027766A3 New crystalline solid forms of o-desvenlafaxine base |
| 04/23/2009 | WO2009019032A3 Novel method for screening brain-active compounds |
| 04/23/2009 | WO2009018511A3 Alpha7 nachr agonists for treating or preventing metabolic disorders |
| 04/23/2009 | WO2009018389A4 Prodrugs of cannabidiol, compositions comprising prodrugs of cannabidiol and methods of using the same |
| 04/23/2009 | WO2009002423A3 Polycyclic guanine derivatives and use thereof |
| 04/23/2009 | WO2007129183A3 Bicyclic heteroaryl compounds as pde10 inhibitors |